Stocks

AstraZeneca shares fall on $39-billion Alexion bill

© Reuters. FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London

(Reuters) – AstraZeneca (NASDAQ:) shares fell 9% on Monday, as investors moved to price in the British drugmaker’s $39 billion deal for U.S. biotech firm Alexion Pharmaceuticals (NASDAQ:), the company’s largest ever and one of this year’s biggest mergers globally.

As part of the deal, Alexion shareholders will get $60 in cash and about $115 worth of equity per share, which based on an average of AstraZeneca’s dollar-denominated American depositary shares price, is a premium of more than $50 per share.

The deal, a bet on rare-disease and immunology drugs, was the result of exclusive talks and no competitive bidder was involved, Chief Executive Officer Pascal Soriot told reporters on Saturday.

In the eight years at the helm https://www.astrazeneca.com/our-company/leadership.html#, Soriot has made AstraZeneca one of the pharmaceutical world’s biggest success stories, raising profits and broadening its portfolio to account for the end of exclusivity periods for some of its biggest selling medicines.

Shares of the company, which is also working on a COVID-19 vaccine, however, have now lost around 17% since hitting a peak in July, as rivals Pfizer (NYSE:) and Moderna (NASDAQ:) moved ahead in the race to get COVID-19 vaccines online.

The purchase will add up to a substantial additional dilution of shares next year and help AstraZeneca diversify from its fast-growing cancer business.

Credit Suisse (SIX:) analysts said AstraZeneca’s price was “reasonable”, but that other bidders may yet emerge to fill in the gap for the U.S. firm’s “full” value.

Analysts from two other brokerages, Cowen and Liberum, called the price respectively “considerable” and “hefty”, while praising the quality of the assets AstraZeneca was buying.

The shares were down 5.5% at 7,706 pence by 0903 GMT, wiping roughly 6 billion pounds ($8.04 billion) off its market valuation of 107.1 billion pounds, as of Friday’s closing price.

($1 = 0.7463 pounds)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Most Related Links :
Business News Governmental News Finance News

Need Your Help Today. Your $1 can change life.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button